Nugene Biopharm Science (Hangzhou) Co., Ltd. are a pharmaceutical manufacturing company located in Zhejiang, China.
We focus on the development and production of Nucleoic acid materials(NTPs), modified NTPs, Cap analgos and nucleoside phosphoramidites.
The parent company Zhejiang Hengkang Pharmaceutical Co., Ltd. was approved by Japan PMDA, EU EMA, NMPA.
NuGene Biopharm Science is a company led by a PhD team dedicated to high-quality mRNA industrialization solutions, mRNA in vivo stability and engineering enzyme update iterations and other key technical barriers and cost barriers.
The company’s existing R&D laboratory is more than 6000 square meters, has a commercial GMP production base of more than 60,000 square meters, first-class inspection and production equipment, a highly educated research and development team, a professional GMP regulatory and registration team, and serves domestic mRNA research and development companies and Manufacturers, provide key raw material supply, cost and CMC solutions.
Can provide nucleotides and modified nucleotides, the product quality has reached the international level, and the cost is controllable, and the batch is stable;
Can provide capping materials for mRNA synthesis to achieve efficient and economical co-transcription capping;
Can provide LNP raw materials that meet the requirements of the nucleic acid delivery system and meet the GMP production conditions;
Can provide mRNA engineering enzymes and adopt absolute quantitative detection methods to ensure that key quality indicators such as enzyme bioactivity and residues are effectively controlled.
